Medlab Clinical Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 2.06
Dividend & YieldN/A$ (N/A)
Beta 1.61
Market capitalization 29.69M
Operating cash flow -10.76M
ESG Scores unknown

Company description

Medlab Clinical Limited, a biotechnology company, researches, develops, and commercializes pharmaceutical and nutraceutical products in Australia. Its lead drug candidate includes NanaBis, an oro–buccal administered equimolar tetrahydrocannabinol (THC) and cannabidiol (CBD) formulation as monotherapy, which is in phase 3 multi-centre, quadruple-blind, randomized- withdrawal active, and placebo-controlled clinical study for the management of opioid-requiring–bone–pain due to metastatic cancer. The company also develops NanoCelle, a patented sub-micron drug delivery platform that enhances drug solubility issues and enables faster absorption and metabolism of active ingredients. In addition, it offers vitamins and supplements; and virtual clinic services. Medlab Clinical Limited was founded in 2012 and is headquartered in Botany, Australia.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities 596.01k 1.68M -781.86k -227.01k
Total Cashflows From Investing Activities -96.48k -340.32k -243.07k -82.9k
Net Borrowings 202.98k 472.27k -1.51M -638.74k
Total Cash From Financing Activities 23.68M 1.78M 8.32M 14.81M
Change To Operating Activities 60.88k -1.17M 1.67M 86.03k
Issuance Of Stock 24.8M 1.3M 10.4M 16.57M
Net Income -4.57M -8.09M -13.4M -12.32M
Change In Cash 18.84M -8.89M -2.38M 4.37M
Effect Of Exchange Rate 28.95k -8.99k -34.73k -2.88k
Total Cash From Operating Activities -4.78M -10.32M -10.42M -10.35M
Depreciation 112.36k 147.49k 961k 873.5k
Change To Account Receivables -355.08k -1.76M 434.74k 23.1k
Other Cashflows From Financing Activities -1.32M -563.3k -563.3k -1.12M
Change To Netincome -216.16k -74.17k -54.21k 534.36k
Capital Expenditures -96.48k -340.32k -243.07k -83.3k

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development 1.03M 1.03M 1.95M 2.1M
Income Before Tax -4.76M -8.17M -13.49M -12.4M
Net Income -4.57M -8.09M -13.4M -12.32M
Selling General Administrative 6.1M 9.5M 9.87M 10.62M
Gross Profit 2.12M 2.33M -851.48k 1.46M
Ebit -4.87M -8.43M -13.37M -12.79M
Operating Income -4.87M -8.43M -13.37M -12.79M
Interest Expense -54.96k -79.77k -197.29k -139.06k
Income Tax Expense
Total Revenue 4.14M 5.43M 2.85M 4.4M
Cost Of Revenue 2.02M 3.1M 3.7M 2.94M
Total Other Income ExpenseNet 108.98k 256.69k -121.14k 386.13k
Net Income From Continuing Ops -4.76M -8.17M -13.49M -12.4M
Net Income Applicable To Common Shares -4.57M -8.09M -13.4M -12.32M

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 2.47M 5.21M 6.53M 5.74M
Total Stockholder Equity 22.88M 15.05M 11.4M 15.14M
Other Current Liabilities 182.12k 81.42k 553.9k 785.65k
Total Assets 24.33M 20.2M 17.79M 20.65M
Common Stock 39.16M 41.62M 51.36M 66.81M
Other Current Assets
Retained Earnings -16.35M -26.64M -40.04M -52.37M
Treasury Stock 68.8k 71.97k 78.19k 699.96k
Cash 20.33M 11.44M 9.06M 13.43M
Total Current Liabilities 2.35M 4.98M 4.43M 4.52M
Other Stockholder Equity 68.8k 71.97k 78.19k 699.96k
Property, Plant, and Equipment 437.77k 631.7k 2.88M 2.08M
Total Current Assets 23.81M 19.09M 14.42M 18.08M
Net Tangible Assets 22.88M 15.05M 11.4M 15.14M
Net Receivables 2.06M 3.81M 3.38M 3.36M
Accounts Payable 990.93k 2.55M 1.82M 1.48M


Insider Transactions

Here are the insider transactions of stock shares related to Medlab Clinical Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Hall (Sean Michael)Purchase at price 0.05 per share.D2022-07-08Chief Executive Officer124.82k
Hall (Sean Michael)Purchase at price 0.07 per share.D2022-04-04Chief Executive Officer109.89k
Hall (Sean Michael)Purchase at price 0.07 per share.D2022-03-30Chief Executive Officer95.74k
Hall (Sean Michael)Purchase at price 0.13 per share.D2021-11-04Chief Executive Officer100k
Dworkin (Alan)D2021-06-30Former2.22M
Hall (Michael Jack)Sale at price 0.21 per share.D2020-12-14Non Executive Chairman100k
Vitetta (Luis)D2020-06-30Divisional Officer100k
Dworkin (Alan)D2020-06-30Chief Financial Officer1M
Hall (Michael Jack)Sale at price 0.17 per share.D2020-04-14Non Executive Chairman68.71k
Hall (Michael Jack)Exercise at price 0.22 per share.D2019-07-01Non Executive Chairman850k
Hall (Sean Michael)Exercise at price 0.17 per share.D2019-07-01Chief Executive Officer2.17M
Hall (Michael Jack)Sale at price 0.28 per share.D2019-05-30Non Executive Chairman38.35k
Townsend (Drew A)Other at price 0.14 per share.D2019-05-24Director (Non-Executive)80k
Hall (Michael Jack)Sale at price 0.28 per share.D2019-05-23Non Executive Chairman30k
Hall (Michael Jack)Purchase at price 0.40 per share.D2018-04-23Non Executive Chairman10k
Hall (Sean Michael)D2018-02-01Chief Executive Officer500k
Hall (Michael Jack)Exercise at price 0.23 per share.D2017-11-16Non Executive Chairman2.65M
Townsend (Drew A)I2016-08-16Director (Non-Executive)
Hall (Sean Michael)I2016-08-16Chief Executive Officer
Hall (Michael Jack)I2016-08-16Non Executive Chairman

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Medlab Clinical Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Medlab Clinical Limited

Here is the result of two systematic investment strategies applied to Medlab Clinical Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Medlab Clinical Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Medlab Clinical Limited:

Medlab Clinical Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -11.32% on the backtest period.

Performance at glance

Performance

-11.32 %

Latent gain

-254.83 $

Invested capital

2250.34 $

Annualized return

-2.75 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Medlab Clinical Limited

This is the result of two momentum investment strategies applied to Medlab Clinical Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Medlab Clinical Limited

The following chart shows all the entries opened by the momentum investment system on Medlab Clinical Limited:

Medlab Clinical Limited momentum entries
  • The first momentum investment strategy would give -7.04% of return on Medlab Clinical Limited. That represents -422.31$ of latent gain with 6000.63$ of employed capital.
  • The second momentum investment strategy would give -7.87% of return on Medlab Clinical Limited. That represents -295.29$ of latent gain with 3750.39$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-7.04 %

Latent gain

-422.31 $

Invested capital

6000.63 $

Annualized return

51.66 %
Performance at glance (2Q Momentum)

Performance

-7.87 %

Latent gain

-295.29 $

Invested capital

3750.39 $

Annualized return

-2.16 %

Momentum equity curve on Medlab Clinical Limited

The following chart shows the equity curve of the two momentum strategies applied to Medlab Clinical Limited:

Medlab Clinical Limited momentum equity

Note: the dividends potentially given by Medlab Clinical Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Medlab Clinical Limited

The following chart shows the employed capital evolution of the two momentum strategies on Medlab Clinical Limited since the beginning:

Medlab Clinical Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Medlab Clinical Limited

Buy the dip entry openings on Medlab Clinical Limited

Medlab Clinical Limited

The performance achieved by the robo-advisor on Medlab Clinical Limited is 109.52%. That represents 547.69$ of latent gain with 500.06$ of employed capital. The following chart shows Medlab Clinical Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Medlab Clinical Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

109.52 %

Latent gain

547.69 $

Invested capital

500.06 $

Annualized return

51.66 %

Equity curve of the strategy applied to Medlab Clinical Limited

The following chart shows the result of the investment strategy applied to Medlab Clinical Limited:

Medlab Clinical Limited

Note: the dividends potentially given by Medlab Clinical Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Medlab Clinical Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Medlab Clinical Limited:

Medlab Clinical Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Medlab Clinical Limited

In this section, I will compare the three previous investment strategies applied to Medlab Clinical Limited.

Equity curve comparison on Medlab Clinical Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Medlab Clinical Limited investment strategy comparison

Employed capital comparison on Medlab Clinical Limited

Medlab Clinical Limited investment comparison

Performance comparison on Medlab Clinical Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -11.32% -254.83$ 2250.34$ -2.75%
Momentum 1 quarter -7.04% -422.31$ 6000.63$ -1.81%
Momentum 2 quarters -7.87% -295.29$ 3750.39$ -2.16%
Non-directional 109.52% 547.69$ 500.06$ 51.66%
Annualized return comparison

Automatic investment

-2.75 %

Momentum 1Q

-2.16 %

Momentum 2Q

-2.16 %

Non-directional

51.66 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Medlab Clinical Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Medlab Clinical Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Medlab Clinical Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Medlab Clinical Limited
Country Australia
City Botany
Address Building A
Phone 61 2 8188 0311
Website www.medlab.co
FullTime employees
Industry Biotechnology
Sector Healthcare
Exchange XASX
Ticker MDC.XASX
Market www2.asx.com.au

Medlab Clinical Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown